Cann Group (ASX:CAN)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
Health Check: Relax! Tariffs shape as the next Y2K as biotechs report ‘nothing to see here’
Lunch Wrap: It’s global carnage as Trump unleashes tariffs
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Renerve all set to become only the second nerve-repair stock on the ASX
Health Check: Despite headwinds, Australia’s third force in pharmacy finds prescription for growth
ASX Small Caps Lunch Wrap: Wall Street says ‘jump’, ASX says ‘how high?’
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
September Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Health Check: Medical pot play Cann Group sees an earnings turnaround through the haze
Bio Curious: Nerve repair house plans to break the IPO drought
Things you may not know about Made in Australia, and ASX stocks that manufacture right here
Weed Week: Jamaican nettletree could be a new, cheaper option to source CBD, says scientists
Weed Week: Big win for cannabis as SAFER Banking Act approved; market remains robust in Australia
